These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 17645708

  • 1. Early steroid withdrawal in solitary pancreas transplantation results in equivalent graft and patient survival compared with maintenance steroid therapy.
    Vessal G, Wiland AM, Philosophe B, Fink JC, Weir MR, Klassen DK.
    Clin Transplant; 2007; 21(4):491-7. PubMed ID: 17645708
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 3. Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.
    Jordan ML, Chakrabarti P, Luke P, Shapiro R, Vivas CA, Scantlebury VP, Fung JJ, Starzl TE, Corry RJ.
    Transplantation; 2000 Jan 27; 69(2):265-71. PubMed ID: 10670637
    [Abstract] [Full Text] [Related]

  • 4. Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.
    Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ.
    Clin Transplant; 2007 Jan 27; 21(1):101-9. PubMed ID: 17302598
    [Abstract] [Full Text] [Related]

  • 5. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG, Winoto J, Chhabra D, Parker MA, Leventhal JR, Kaufman DB.
    Transplantation; 2007 May 27; 83(10):1324-9. PubMed ID: 17519781
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.
    Hussain SM, Marcus RJ, Ko TY, Nashar K, Thai NL, Sureshkumar KK.
    Exp Clin Transplant; 2016 Jun 27; 14(3):287-93. PubMed ID: 27221720
    [Abstract] [Full Text] [Related]

  • 7. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
    Thomusch O, Wiesener M, Opgenoorth M, Pascher A, Woitas RP, Witzke O, Jaenigen B, Rentsch M, Wolters H, Rath T, Cingöz T, Benck U, Banas B, Hugo C.
    Lancet; 2016 Dec 17; 388(10063):3006-3016. PubMed ID: 27871759
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil in pancreas transplantation.
    Gruessner RW, Sutherland DE, Drangstveit MB, Wrenshall L, Humar A, Gruessner AC.
    Transplantation; 1998 Aug 15; 66(3):318-23. PubMed ID: 9721799
    [Abstract] [Full Text] [Related]

  • 9. Steroid withdrawal in pancreas transplant recipients.
    Humar A, Parr E, Drangstveit MB, Kandaswamy R, Gruessner AC, Sutherland DE.
    Clin Transplant; 2000 Feb 15; 14(1):75-8. PubMed ID: 10693640
    [Abstract] [Full Text] [Related]

  • 10. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
    Libório AB, Mendoza TR, Esmeraldo RM, Oliveira ML, Paes FJ, Silva Junior GB, Daher EF.
    Int Immunopharmacol; 2011 Nov 15; 11(11):1832-6. PubMed ID: 21835269
    [Abstract] [Full Text] [Related]

  • 11. Beneficial outcomes of a steroid-free regimen with thymoglobulin induction in pancreas-kidney transplantation.
    Tanchanco R, Krishnamurthi V, Winans C, Wee A, Duclos A, Nurko S, Fatica R, Lard M, Poggio ED.
    Transplant Proc; 2008 Jun 15; 40(5):1551-4. PubMed ID: 18589149
    [Abstract] [Full Text] [Related]

  • 12. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
    Freise CE, Kang SM, Feng S, Posselt A, Hirose K, Hirose R, Stock P.
    Transplant Proc; 2004 May 15; 36(4):1067-8. PubMed ID: 15194370
    [Abstract] [Full Text] [Related]

  • 13. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
    Humar A, Crotteau S, Gruessner A, Kandaswamy R, Gruessner R, Payne W, Lake J.
    Clin Transplant; 2007 May 15; 21(4):526-31. PubMed ID: 17645714
    [Abstract] [Full Text] [Related]

  • 14. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y, Tojimbara T, Iwadoh K, Koyama I, Nanmoku K, Kai K, Sannomiya A, Nakajima I, Fuchinoue S, Teraoka S.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1984-92. PubMed ID: 17161352
    [Abstract] [Full Text] [Related]

  • 15. Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients.
    Montero N, Webster AC, Royuela A, Zamora J, Crespo Barrio M, Pascual J.
    Cochrane Database Syst Rev; 2014 Sep 15; 2014(9):CD007669. PubMed ID: 25220222
    [Abstract] [Full Text] [Related]

  • 16. Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression.
    Stratta RJ, Lo A, Shokouh-Amiri MH, Egidi MF, Gaber LW, Gaber AO.
    Transpl Int; 2003 Mar 15; 16(3):154-60. PubMed ID: 12664209
    [Abstract] [Full Text] [Related]

  • 17. Long-term results of pancreas transplantation under tacrolius immunosuppression.
    Jordan ML, Shapiro R, Gritsch HA, Egidi F, Khanna A, Vivas CA, Scantlebury VP, Fung JJ, Starzl TE, Corry RJ.
    Transplantation; 1999 Jan 27; 67(2):266-72. PubMed ID: 10075592
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.
    Transplantation; 2009 Sep 27; 88(6):810-9. PubMed ID: 19920781
    [Abstract] [Full Text] [Related]

  • 19. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.
    Freise CE, Kang SM, Feng S, Hirose R, Stock P.
    Arch Surg; 2003 Oct 27; 138(10):1121-5; discussion 1125-6. PubMed ID: 14557130
    [Abstract] [Full Text] [Related]

  • 20. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner AC, Sutherland DE.
    Clin Transpl; 2008 Oct 27; ():45-56. PubMed ID: 19708445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.